EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuroendocrine tumours through an epigenetic lens: Emerging insights for diagnosis and treatment

Victoria Jacquot, Benjamin Chevalier, Thomas Walter, Benjamin Gibert, Maria Ouzounova

Journal of Neuroendocrinology · 2026-06 · 38 (6)

DOI: 10.1111/jne.70211 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 07.06.2026. Verfasst von Victoria Jacquot und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Technologies for Health, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université …. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Epigenesis, Genetic. Die Arbeit nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine tumours (NETs) are well‐differentiated epithelial neuroendocrine neoplasms that frequently develop in the small intestine, pancreas, and lungs. NETs originate from neuroendocrine cells specialized in hormone secretion implicated in a number of physiological processes. Their malignant transformation is characterized by low mutational burden, suggesting that epigenetic mechanisms may be at play. Recent understanding of epigenetic events driving cancer cell plasticity and tumour initiation has led to advances in the diagnosis and prognosis of NETs. Here, we provide a brief overview of NETs, including their current diagnosis and management, and present recent progress in understanding the role of epigenetic regulation, highlighting how this may influence NET tumorigenesis and may be used in therapeutic applications. Finally, this literature review emphasizes the need to gather more data on these rare malignancies to improve patient outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsEpigenesis, GeneticHumansAnimalsDNA Methylation

Stichwörter der Autor:innen

DNA methylationepigenetic‐targeting drugsneuroendocrine tumorsnon‐coding RNAshistone modifications

Autor:innen und Institutionen

  • Gastroenterology and Technologies for Health, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon1, Lyon, France.
  • Hospices Civils de Lyon, Hôpital Edouard Herriot, Service de Gastroentérologie et d'Oncologie Digestive, Lyon, France.

Zitieren

APA

Jacquot, V., Chevalier, B., Walter, T., Gibert, B., & Ouzounova, M. (2026). Neuroendocrine tumours through an epigenetic lens: Emerging insights for diagnosis and treatment. Journal of Neuroendocrinology, 38(6). https://doi.org/10.1111/jne.70211

Vancouver

Jacquot V, Chevalier B, Walter T, Gibert B, Ouzounova M. Neuroendocrine tumours through an epigenetic lens: Emerging insights for diagnosis and treatment. Journal of Neuroendocrinology. 2026;38(6). doi:10.1111/jne.70211

BibTeX
@article{Jacquot2026,
  author = {Jacquot, Victoria and Chevalier, Benjamin and Walter, Thomas and Gibert, Benjamin and Ouzounova, Maria},
  title = {Neuroendocrine tumours through an epigenetic lens: Emerging insights for diagnosis and treatment},
  journal = {Journal of Neuroendocrinology},
  year = {2026},
  volume = {38},
  number = {6},
  doi = {10.1111/jne.70211}
}
Kostenlos starten →